NASDAQ$WBA
Walgreens Boots Alliance Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Walgreens' third quarter 2021 results exceeded expectations, with the company raising its full-year guidance.
Walgreens Boots Alliance reported a strong third quarter, exceeding expectations with sales increasing by 12.1% to $34.0 billion and adjusted EPS growing by 83.4% to $1.51. The company raised its full-year guidance to around 10% growth in constant currency adjusted EPS from continuing operations.
- Total sales increased 12.1 percent to $34.0 billion.
- Total adjusted EPS increased 83.4 percent to $1.51.
- The company raised guidance to around 10 percent growth in constant currency adjusted EPS from continuing operations.
- Walgreens has administered more than 25 million COVID-19 vaccinations to date.
Headline financials
Revenue & EPS history
Walgreens · Revenue · Quarterly
$34B
Revenue by segment
Walgreens · $7.76B total across 2 segments · Q4 2023
- International$5.78B—74.6%
- U.S. Healthcare$1.97B+217.0%25.4%
Forward guidance
The company raised fiscal 2021 guidance from mid-to-high single digit growth to around 10 percent growth in constant currency adjusted EPS from continuing operations. The revised guidance reflects strong results in the third quarter and greater clarity on the impact of COVID-19 vaccinations.
Tailwinds
- Strong results in the third quarter
- Greater clarity on the impact of COVID-19 vaccinations
- Company raised fiscal 2021 guidance to around 10 percent growth in constant currency adjusted EPS from continuing operations.
- Mass personalization boosted Walgreens retail sales by 100 basis points in the third quarter.
- The company is on track to deliver in excess of $2 billion in annual cost savings by fiscal 2022.
Headwinds
- Challenges lie ahead
- COVID-19 related costs
- Higher growth investments
- Adverse impacts from the store optimization programs
- Travel locations in airports and train stations continued to face challenges.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 16 quarterly earnings reports
-0.1%
Avg return
Earnings day
+0.4%
Avg return
5 days after
-1.9%
Avg return
30 days after
53%
33 / 62 earnings
Positive
+29.1%
Q1 2025
Best reaction
-22.7%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q3 2025 | +0.4% | +1.5% | +2.7% | |
| Q2 2025 | -1.1% | +0.5% | +4.1% | |
| Q1 2025 | +29.1% | +36.1% | +10.0% | |
| Q4 2024 | +23.0% | +18.7% | -2.0% | |
| Q3 2024 | -22.7% | -26.0% | -24.5% | |
| Q2 2024 | -7.0% | -10.9% | -15.7% | |
| Q1 2024 | -2.2% | -0.6% | -11.4% | |
| Q4 2023 | +2.9% | +2.1% | -7.3% | |
| Q3 2023 | -7.9% | -10.2% | -3.0% | |
| Q2 2023 | +3.7% | +5.0% | +6.6% | |
| Q1 2023 | -2.3% | -2.1% | -1.1% | |
| Q4 2022 | +4.1% | +3.8% | +29.4% | |
| Q3 2022 | -5.7% | -5.7% | -2.9% | |
| Q2 2022 | -7.6% | -8.4% | -10.6% | |
| Q1 2022 | -0.3% | +0.6% | -10.0% | |
| Q4 2021 | +3.5% | +1.5% | +4.8% | |
| Q3 2021 | -8.4% | — | — | |
| Q2 2021 | +3.3% | — | — | |
| Q1 2021 | +5.1% | — | — | |
| Q4 2020 | +4.2% | — | — | |
| Q3 2020 | -5.1% | — | — | |
| Q2 2020 | -5.4% | — | — | |
| Q1 2020 | -7.8% | — | — | |
| Q4 2019 | +1.5% | — | — | |
| Q3 2019 | +4.4% | — | — | |
| Q2 2019 | -13.6% | — | — | |
| Q1 2019 | -8.2% | — | — | |
| Q4 2018 | +1.6% | — | — | |
| Q3 2018 | -9.4% | — | — | |
| Q2 2018 | -0.7% | — | — | |
| Q1 2018 | -3.4% | — | — | |
| Q4 2017 | -0.3% | — | — | |
| Q3 2017 | +1.6% | — | — | |
| Q2 2017 | -1.0% | — | — | |
| Q1 2017 | +0.1% | — | — | |
| Q4 2016 | +5.7% | — | — | |
| Q3 2016 | -3.6% | — | — | |
| Q2 2016 | -3.0% | — | — | |
| Q1 2016 | +1.8% | — | — | |
| Q4 2015 | -11.9% | — | — | |
| Q3 2015 | +8.4% | — | — | |
| Q1 2014 | +4.9% | — | — | |
| Q2 2015 | +4.9% | — | — | |
| Q4 2013 | +4.9% | — | — | |
| Q1 2015 | +3.2% | — | — | |
| Q4 2014 | -0.9% | — | — | |
| Q3 2014 | +0.6% | — | — | |
| Q2 2014 | +1.0% | — | — | |
| Q3 2013 | -1.0% | — | — | |
| Q2 2013 | +0.4% | — | — | |
| Q1 2013 | +1.6% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | -3.2% | — | — | |
| Q2 2012 | -1.9% | — | — | |
| Q1 2012 | +4.1% | — | — | |
| Q4 2011 | +0.4% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q2 2011 | +1.8% | — | — | |
| Q1 2010 | +2.5% | — | — | |
| Q4 2010 | +1.8% | — | — | |
| Q3 2010 | -0.1% | — | — | |
| Q2 2009 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro